Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., July 27 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on August 24, 2009 to all sto...

CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share

Merger Adds Complementary Products and Expands Sales Channels for Both Companies SAN DIEGO, June 9 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC ), the innovator and leader of BioZ(R) Impedance Cardiography (ICG) technology, today announced that it has entered into a definitive mer...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., April 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on May 22, 2009 to all stockholders of record on...

Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences

LEVANGER, Norway, April 23 /PRNewswire/ -- HUNT Biosciences, the commercial arm of the HUNT Study and associated biobank today announced the appointment of former GE Healthcare director Per Foss as its new CEO. The company provides pharmaceutical and healthcare companies with biomarker discove...

An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share

NEW YORK, Feb. 12 /PRNewswire/ -- JLL Partners, a leading private equity investment fund ("JLL") and PharmaNet Development Group, Inc. ("PharmaNet") announced today that JLL PharmaNet Holdings, LLC ("Parent"), through its wholly-owned subsidiary, PDGI Acquisition Corp. ("Purchaser"), each of which...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on March 6, 2009 to all stockholders of record on ...

Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share

SEATTLE, Feb. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) announced today that it has issued 6,634 shares of Series F Preferred Stock in exchange for 6,634 shares of CTI's Series A, B and C Convertible Preferred Stock. The exchange constitutes 83% in interest of ...

Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash

BASEL, Switzerland, Jan. 30 /PRNewswire/ -- Roche announced today that it intends to commence a cash tender offer for all outstanding publicly-held shares of Genentech at US$ 86.50 per share. Roche, which currently owns 55.8% of the Genentech outstanding shares, expects to commence the tender offe...

Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55

Full Year 2008 Revenue Increased 2 Percent to $15.0 Billion; Fourth Quarter 2008 Revenue Flat at $3.75 Billion Full Year 2008 GAAP Earnings Per Share Increased 38 Percent to $3.90; Fourth Quarter 2008 GAAP Earnings Per Share Increased 20 Percent to $0.91 2009 Total Revenue Expected to be...

BVF Acquisition LLC, a Wholly-Owned Subsidiary of Biotechnology Value Fund, L.P., Commences Tender Offer for Any and All Outstanding Shares of Avigen at $1.00 Per Share

NEW YORK, Jan. 23 /PRNewswire/ -- BVF Acquisition LLC (the "Purchaser"), a wholly owned subsidiary of Biotechnology Value Fund, L.P. ("BVF"), announced today that it has commenced a cash tender offer to purchase any and all of the outstanding common stock of Avigen, Inc. (Nasdaq: AVGN ) ("Avigen...

Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $1.00 Per Share

Tender Offer provides stockholders with a near-term cash alternative if BVF nominees are elected BVF reaffirms support for downside-protected merger with MediciNova NEW YORK, Jan. 15 /PRNewswire/ -- Biotechnology Value Fund, L.P. ("BVF") announced today that it intends to make a cash te...

Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year

- Fourth quarter constant currency revenue growth of 12.9 percent - Full year revenue growth of 11.1 percent (9.0 percent, constant currency) and improving profitability reflects success of strategic initiatives - Management reaffirms annual financial guidance for fiscal year 2009 BAT...

CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007

Revenues increased 21 percent in third quarter of 2008 versus third quarter of 2007 ATLANTA, Oct. 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a biomaterials, medical device and tissue processing company, announced today that revenues for the third qu...

Amgen's Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23

Third Quarter 2008 Revenue Increased 7 Percent to $3.9 Billion Third Quarter 2008 GAAP Earnings Per Share were $1.09, an Increase from Third Quarter 2007 GAAP Earnings Per Share of $0.18 Full Year Revenue Guidance Raised from $14.6 Billion - $14.9 Billion to ...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on November 17, 2008 to all stockholders of re...

Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008

BANGOR, Maine, Oct. 14 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER ) reported results for the fiscal year ended June 30, 2008. Revenues for the fiscal year ended June 30, 2008 increased $6.6 million or 10.2% to $71.2 million from $64.6 million as reported for the previous...

Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share

INDIANAPOLIS, Oct. 14 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today that its wholly-owned subsidiary, Alaska Acquisition Corporation, has commenced its tender offer for all outstanding shares of ImClone Systems Incorporated (Nasdaq: IMCL ) at a price of $70.00 ...

Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share

- Launch of Generic Yasmin(R) Oral Contraceptive Contributes to Higher U.S. Generic Sales - Continued Strong European and Rest of the World Sales - Increased Proprietary Product Sales - Company Reiterates 2008 Adjusted EPS Guidance of $2.75 - $...

CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007

Company posts record quarterly revenues of $27.2 million ATLANTA, July 31 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a biomaterials, medical device and tissue processing company, announced today that revenues for the second quarter of 2008 increased 18 percent to $27.2 mil...

Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash

- Combination to enhance innovation by allowing for diversity of research approaches while also encouraging sharing of IP, technologies, partnerships and other key assets - Improved operational efficiency to result from reduced complexity, elimination of duplication...

220 Companies Place Switzerland First in Biotech Density Per Capita

14,000 Employees in Industry with Revenues of 7 Billion Swiss Francs 300+ Research Groups Focus on Biotech NEW YORK, June 3 /PRNewswire/ -- With 148 biotech companies and 72 suppliers to the industry -- or 220 firms involved in the business -- Switzerland has the world's high...

Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share

- Strong European and Rest of the World Sales - Proprietary Product Sales Increase, Portfolio Expanded - Company Provides Updated Adjusted Calendar 2008 EPS Guidance of $2.75 - $3.05 MONTVALE, N.J., May 8 /PRNewswire-FirstCall/ -- Barr Pharm...

Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%

EATONTOWN, N.J., May 1 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biological products for regenerative healing, announced today that revenue for the first quarter of 2008 increased 10% to $27.6 million from $25.2 million for the first quarter ...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., April 25 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on May 23, 2008 to all stockholders of record...

Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share

ARLINGTON, Va., April 23 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a $2,500,000 pri...

Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion

- Acquisition Accelerates Takeda's Vision of Becoming a Global Leader in Oncology - OSAKA, Japan, and CAMBRIDGE, Mass., April 10 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Millennium Pharmaceuticals, Inc. (Nasdaq: ML...

Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter

MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today reported net earnings of $128.4 million, or $1.18 per share, for the year ended December 31, 2007 on revenues of $2.5 billion. On a non-GAAP basis, adjusted earnings per share were $3.16 for 2007. ...

Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007

EATONTOWN, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that total revenue for the year ending December 31, 2007 increased 5% to $104.3 million compared to $99.2 million...

AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000

TUSTIN, Calif., Jan. 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc., is an international biopharma company that, together with Jade, en...

Roche to Acquire Ventana for $89.50 per share

Roche and Ventana Reach Definitive Merger Agreement BASEL, Switzerland and TUCSON, Ariz., Jan. 22 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX: RHHBY), a world-leading healthcare provider of pharmaceuticals and diagnostics, and Ventana Medical Systems ("Ventana") (Nasdaq...

The Ensign Group, Inc. Declares Quarterly Dividend of $0.04 Per Share

MISSION VIEJO, Calif., Dec. 26 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash...

Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues

- Company Establishes New Quarterly Records for Product Sales ($97.4 Million, Up 17% Versus Prior Year) and Total Revenues ($101.7 Million, Up 10%) - - Company Reports EPS of $0.31, 11% Higher than Prior Year - - Company Expects Full-Year EPS of $1.50 to $...

PPD Reports Third Quarter 2007 Financial Results; Announces Increase in Annual Cash Dividend From $0.12 to $0.40 Per Year

Third Quarter Highlights - Gross new authorizations of $570.6 million, a sequential increase of 20.6 percent, resulting in a net book-to-bill ratio of 1.4 - Cash flow from operations of $61.6 million, resulting in $146.3 million cash flow from ope...

Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share

CAMBRIDGE, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ ) confirmed today that it will not change its purchase price for Bioenvision (Nasdaq: BIVN ) at $5.60 in cash per outstanding common share as set forth in the merger agreement between the two companies. Ge...

STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%

PARIS, August 28 /PRNewswire-FirstCall/ -- The Board of Directors, meeting on 28 August 2007, under the chairmanship of Albert Saporta approved the consolidated financial statements at 30 June 2007: (EUR millions) 2007 % of 2006 % of % change HY1 ...

H2Diesel Completes 3 Million Gallon Per Year Pilot Facility

HOUSTON, Aug. 16 /PRNewswire-FirstCall/ -- H2Diesel Holdings, Inc. ("H2Diesel") (OTC Bulletin Board: HTWO), announced today that it has placed into service its first bio-fuel production plant, a 3 million gallon per year pilot facility, jointly developed with Twin Rivers Technologies L.P. ("Tw...

DOE awards $377 million in funding for 46 energy frontier research centers

... made available through the Recovery Act with the remaining $100 million made from DOE's FY2009 budget. The 46 EFRCs are being funded at $2-5 million per year each for a planned initial five-year period and were selected from a pool of applications received in response to a solicitation issued by the U....

Schering-Plough Shareholders Approve Merger With Merck

... of the merger, it is anticipated that the combined company will continue the dividend policies of Merck, currently a quarterly cash dividend of $0.38 per common share (subject to declaration by the board of directors and a variety of factors including business and financial considerations). DISC...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... ====== ====== ====== ====== Shares used in computing basic and diluted net loss per share 41,098,270 41,128,590 41,098,270 41,100,676 Contacts: Investor Relations: Cameron Associates Kevin McGrath 212.245.45...

Novavax Reports Second Quarter 2009 Financial Results

...oday reported a net loss of $8.5 million, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4 million, or $0.15 per share, for the second quarter of 2008. Fo...vax reported a net loss of $16.9 million, or $0.22 per share, as compared to a net loss of $17.1 million,...